Separate terms with OR to return results that match either term.
 
Clear All

9,018 Matching ResultsExport these results
Click column titles once to sort ascending, and twice to sort descending.
Show Entries
NDC-11 (Package) NDC-9 (Product) Generic Name Brand Name Strength SEER*Rx Category Major Class Minor Class (Ascending) Administration Route Package Effective Date Package Discontinuation Date Status
70518-0892-00 70518-0892 Ondansetron Ondansetron 4.0 mg/1 Ancillary Therapy Oral Dec. 12, 2017 In Use
70518-0956-00 70518-0956 Ondansetron Ondansetron 2.0 mg/mL Ancillary Therapy Intramuscular, Intravenous Jan. 12, 2018 In Use
70518-1042-00 70518-1042 ondansetron hydrochloride ondansetron hydrochloride 4.0 mg/1 Ancillary Therapy Oral March 1, 2018 In Use
68083-0161-10 68083-0161 Mesna Injection Mesna 100.0 mg/mL Ancillary Therapy Intravenous Dec. 20, 2017 In Use
68083-0161-01 68083-0161 Mesna Injection Mesna 100.0 mg/mL Ancillary Therapy Intravenous Dec. 20, 2017 In Use
70860-0209-10 70860-0209 mesna Mesna 100.0 mg/mL Ancillary Therapy Intravenous Feb. 28, 2018 In Use
70860-0209-11 70860-0209 mesna Mesna 100.0 mg/mL Ancillary Therapy Intravenous Feb. 28, 2018 In Use
70771-1152-01 70771-1152 Finasteride Finasteride 5.0 mg/1 Ancillary Therapy Oral Dec. 5, 2017 In Use
70771-1152-00 70771-1152 Finasteride Finasteride 5.0 mg/1 Ancillary Therapy Oral Dec. 5, 2017 In Use
70771-1152-04 70771-1152 Finasteride Finasteride 5.0 mg/1 Ancillary Therapy Oral Dec. 5, 2017 In Use
70771-1152-03 70771-1152 Finasteride Finasteride 5.0 mg/1 Ancillary Therapy Oral Dec. 5, 2017 In Use
67296-1562-03 67296-1562 Ondansetron Hydrochloride Ondansetron Hydrochloride 4.0 mg/1 Ancillary Therapy Oral Jan. 1, 2018 In Use
55700-0627-10 55700-0627 Ondansetron Hydrochloride Ondansetron Hydrochloride 8.0 mg/1 Ancillary Therapy Oral May 18, 2018 In Use
55700-0627-12 55700-0627 Ondansetron Hydrochloride Ondansetron Hydrochloride 8.0 mg/1 Ancillary Therapy Oral May 18, 2018 In Use
55700-0627-20 55700-0627 Ondansetron Hydrochloride Ondansetron Hydrochloride 8.0 mg/1 Ancillary Therapy Oral May 18, 2018 In Use
55700-0627-30 55700-0627 Ondansetron Hydrochloride Ondansetron Hydrochloride 8.0 mg/1 Ancillary Therapy Oral May 18, 2018 In Use
55700-0631-06 55700-0631 Ondansetron Hydrochloride Ondansetron Hydrochloride 4.0 mg/1 Ancillary Therapy Oral May 25, 2018 In Use
55700-0631-10 55700-0631 Ondansetron Hydrochloride Ondansetron Hydrochloride 4.0 mg/1 Ancillary Therapy Oral May 25, 2018 In Use
55700-0631-20 55700-0631 Ondansetron Hydrochloride Ondansetron Hydrochloride 4.0 mg/1 Ancillary Therapy Oral May 25, 2018 In Use
55700-0631-30 55700-0631 Ondansetron Hydrochloride Ondansetron Hydrochloride 4.0 mg/1 Ancillary Therapy Oral May 25, 2018 In Use
70720-0950-36 70720-0950 goserelin acetate ZOLADEX 3.6 mg/1 Hormonal Therapy GnRH Agonist Subcutaneous March 31, 2018 In Use
16714-0815-01 16714-0815 zoledronic Acid Zoledronic Acid 4.0 mg/5mL Ancillary Therapy Intravenous May 30, 2018 In Use
54288-0100-01 54288-0100 ZOLEDRONIC ACID ZOLEDRONIC ACID 4.0 mg/5mL Ancillary Therapy Intravenous April 2, 2018 In Use
00527-1452-06 00527-1452 Dronabinol Dronabinol 10.0 mg/1 Ancillary Therapy Oral May 18, 2018 In Use
00527-1451-06 00527-1451 Dronabinol Dronabinol 5.0 mg/1 Ancillary Therapy Oral May 18, 2018 In Use

Found 9,018 results in 7 millisecondsExport these results